Czechia vs Indonesia: Treatment success rate for patients treated for MDR-TB
Czechia
59.0%
in 2022
Indonesia
59.0%
in 2022
Czechia rank
125th
Indonesia rank
125th
Treatment success rate for patients treated for MDR-TB over time
- Czechia
- Indonesia
How they compare
Czechia currently reports 59.0% against 59.0% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2009 it was Indonesia ahead.
Czechia ranks 125th and Indonesia ranks 125th of 163 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Czechia | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 74.0% | 74.0% | Indonesia |
| 2010s | 41.8% | 51.4% | 9.6% | Indonesia |
| 2020s | 38.0% | 56.0% | 18.0% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Czechia or Indonesia?
- Czechia, at 59.0% against 59.0% in Indonesia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Czechia and Indonesia?
- 0.0%, with Czechia ahead.
- How many years of comparable data are there for Czechia and Indonesia?
- 12 years are reported by both, from 2009 to 2022.
- How do Czechia and Indonesia rank globally for treatment success rate for patients treated for mdr-tb?
- Czechia ranks 125th and Indonesia ranks 125th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.